Review Article

Effects and Underlying Mechanisms of Bioactive Compounds on Type 2 Diabetes Mellitus and Alzheimer’s Disease

Table 1

Effects of bioactive compounds on Alzheimer’s disease (in vitro studies).

Bioactive compoundsModelsTreatmentEffectsSpecific mechanism of actionReference

Polyphenols
ResveratrolPC12 cells12.5, 25, 50, and 100 μM, 2 h prior to the Aβ25–35, 24 or 48 h↑Cell viability
↓Aβ25–35-induced intracellular Ca2+ level
↓Cell apoptosis
↑SIRT1
↓ROCK1
[56]
QuercetinPrimary rat neuronal cellsLow dose: 5 and 10 μM,
High dose: 20 and 40 μM,
24 h
↓Aβ1-42-induced apoptotic cell death and cell toxicity at low dose
↑Toxic at high dose
↓Lipid peroxidation
↓Oxidative stress
[68]
GenisteinBV-2 microglia cells50 μM, 2 h before incubation with Aβ25–35, 24 h↑Cell viability
↓Aβ25–35-induced inflammatory damage
↓The expression of TLR4, NF-κB,
↓The activity of NF-κB
[80]
EGCGHEK-293 cells15 and 20 μM, 1-3 daysConvert large, mature amyloid-β fibrils into smaller, amorphous, and nontoxic aggregatesDirectly binds to β-sheet-rich aggregates and mediates the conformational change[103]
HesperidinNeuro-2A cells20 μM, 6 h pretreatment before exposure to Aβ1-42↓Aβ-induced impairment of insulin signaling and glucose uptake↓Aβ-induced autophagy
↑IRS-PI3K-Akt signal transduction
[115]
AnthocyaninsNeuro-2A cells50 μM malvidin or ononin with Aβ, 48 h↓Aβ-induced neurotoxicity, cell cycle arrest↑Ca2+ homeostasis
↓Aβ-induced ROS
[125]
CurcuminMacrophages from AD patients0.1 μM↓Aβ aggregates↑Aβ uptake by macrophages[238]
RutinAPPswe cells1, 5, and 10 μM↓The formation of Aβ fibrils and disaggregated Aβ fibrils
↓Neurotoxicity
Free-radical scavenger activity[152]
Carotenoid
LycopeneRat cortical neurons0.1, 1, 2, and 5 μM, 4 h pretreatment before exposure to Aβ↑Cell viability
↓Apoptotic rate
↓Aβ-induced ROS
↓Mitochondrial membrane potential depolarization
[192]

Vitamins
Vitamin A100, 150, and 250 μM retinoid acid↓Aβ42 and Aβ40 oligomerization
↓Cell toxicity
Specific binding of retinoic acid to the C-terminal portion of Aβ[204]
Vitamin DROS 17/2.8 cell10−6, 10−8, 10−10, and 10−12 M, 6 h↑NGF expression↑AP-1 binding activity in the NGF promoter[222]
Vitamin ERat cortical neurons1 mM of Trolox (vitamin E derivative) with Aβ↓Aβ-induced tau phosphorylation↓P38 MAPK[231]